Skip to main content
Erschienen in: Cardiovascular Ultrasound 1/2019

Open Access 01.12.2019 | Research

The value of left ventricular strain–volume loops in predicting response to cardiac resynchronization therapy

verfasst von: Mengruo Zhu, Haiyan Chen, Zibire Fulati, Yang Liu, Yangang Su, Xianhong Shu

Erschienen in: Cardiovascular Ultrasound | Ausgabe 1/2019

Abstract

Background

Three-dimensional (3D) speckle tracking imaging (STI) allows the simultaneous assessment of left ventricular (LV) strain and volume. We aim to explore the value of LV strain–volume loops in predicting response to cardiac resynchronization therapy (CRT).

Methods

Forty heart failure (HF) patients scheduled for CRT and twenty healthy individuals were enrolled. All subjects received a 3D echocardiography and 3D STI analysis to acquire LV global and segmental principal strain (PS) and volume simultaneously. Values were plotted in a Cartesian system to construct PS–volume loop which was assessed using the two characteristics of the linear fitting curve: the slope and the coefficient of determination (R2-S/D coupling).

Results

HF patients at baseline showed significantly lower slope and R2-S/D coupling of all PS–volume loops than healthy subjects. As for as comparing Segmental PS–Global volume loop at baseline, Midseptal R2-S/D coupling was lower and Midlateral slope was higher in CRT responders than in non-responders. For each individual, the abnormal segmental heterogeneity of Midseptal slope and R2-S/D coupling were lower than Midlateral was observed only in responders. At follow-up, significant improvements of the Midseptal slope and R2-S/D coupling were observed in responders. Midseptal R2-S/D coupling at baseline was an independent predictor of CRT response and the cut-off value of 0.55 was recommended with sensitivity of 89% and specificity of 77%.

Conclusions

Analysis of strain–volume loops could provide unique information for predicting response to CRT. Assessment of septal myocardial wasted work at baseline is helpful to improve patient selection for CRT.
Abkürzungen
2D
two-dimensional
3D
three-dimensional
AUC
area under the curve
CI
confidence interval
CRT
cardiac resynchronization therapy
EDV
end-diastolic volume
EF
ejection fraction
ESV
end-systolic volume
HF
heart failure
LV
left ventricular
PS
principal strain
ROC
receiver operating characteristic
SDI
strain delay index
STI
speckle tracking imaging
Tmsv-SD%
standard deviation of time to minimum systolic volume corrected by R-R interval
TpPS-SD%
standard deviation of time to peak principal strain corrected by R-R interval

Introduction

Cardiac resynchronization therapy (CRT) is an established treatment for patients with dyssynchronous heart failure (DHF) [1], meanwhile growing evidence supports that the secondary changes of CRT in molecular and cellular play an important role in reversing left ventricular (LV) remodeling. Previous study [2] has demonstrated that molecular polarization within the dyssynchronous LV was consistent with segmental heterogeneity of myocardial load distribution. Strain describes exactly myocardial deformation under the action of hemodynamic load. However, most of segmental strain analysis proposed previously [3] neglected the dynamic relationship of strain with volume load changing across the cardiac cycle. As suggested in Carasso’s study [4], LV segmental straintime curve morphology is actually highly predictive of response to CRT, while the same values of strain peaks or timings could be observed with different strain curve morphologies [5].
In our study, we hypothesized that the new approach, based on the simultaneous strain–volume analysis which combining temporal changing data from function and structure, could provide unique information for predicting CRT response. Three-dimensional (3D) speckle tracking imaging (STI) allows the simultaneous evaluation of cardiac principal strain (PS) and volume changes frame-by-frame. Since 3D PS overcoming limitations of geometry-dependent reference directions (i.e. longitudinal, radial, and circumferential) [6, 7], it has been proven that 3D PS correlated well with cardiac muscle fiber arrangements and could more accurately detect regional myocardial mechanical alterations [8, 9]. To validate our hypothesis, data of each patient across one cardiac cycle were plotted in a Cartesian system to develop the PS–volume loop which was analyzed by two characteristics of the linear fitting curve: the slope and the coefficient of determination which reflecting the degree of systolic–diastolic coupling (R2-S/D coupling). Slope reflects dynamic relationship between strain responses alongside volume changing. As to the R2-S/D coupling, the smaller its value is, the severer the degree of systolic–diastolic uncoupling is, which indicating that (global or segmental) myocardial efficiency reduced in dyssynchronous LV because myocardial systolic shortening and diastolic lengthening doesn’t synchronize with chamber volume decreasing and increasing.

Methods

Study population

A total of 40 consecutive HF patients who were firstly scheduled for CRT were prospectively enrolled. Indications for CRT according to the 2016 European Society of Cardiology (ESC) guidelines [10] were as follow: symptomatic patients with HF with a QRS duration ≥130 ms and LVEF ≤35%, in NYHA functional class III or IV despite optimal medical treatment. Patients were excluded for the following reasons: narrow QRS, right bundle branch block (RBBB), a history of cardiac surgery, absence of clinical follow-up and poor echocardiography images. Left bundle branch block (LBBB) was diagnosed according to the criteria proposed by 2013 ESC guidelines [11] Class 1 Recommendation for CRT, namely a wide QRS duration with QS or rS in V1, broad (frequently notched or slurred) R wave in leads I, aVL, V5 or V6, and absence of q waves in leads V5 and V6. Intraventricular conduction delay [12] was diagnosed as non-specific manner QRS morphology that did not fit the criteria for LBBB and RBBB. Response to CRT was defined as a reduction in LV end-systolic volume ≥ 15% at 6-month follow-up in comparison with baseline value measured by echocardiography.
Control subjects, matched for age and gender, were selected without documented cardiovascular diseases and history of cardiovascular medication and with normal cardiac function using the American Society of Cardiology (ASE) guidelines for cardiac chamber quantification [13].
This study was approved by the medical ethics committee of our hospital, and informed consent was obtained from all subjects.

Echocardiography

All subjects in the left lateral decubitus, with a synchronous Electrocardiogram connected, underwent transthoracic echocardiography using a Philips iE33 ultrasound machine (Philips Medical Systems, Eindhoven, The Netherlands) equipped with a S5–1 and X3–1 probe. A complete and standard 2D echocardiographic assessment and real-time 3D echocardiography were performed on HF patients before CRT device implantation and then 6-month follow-up after CRT as well as healthy controls.

Two-dimensional echocardiography

Conventional 2D, M-mode and Doppler echocardiographic parameters were measured according to the recommendations of ASE guidelines [13].

Three-dimensional speckle-tracking imaging

3D images were imported to the 4D speckle-tracking workstation, TomTec-Image Arena 4D Cardiac Performance Analysis; TomTec Imaging System, GMBH, Germany) and analyzed according to the following steps: First, the best cardiac cycle of the full-volume 3D acquisition was chosen, orientating one reference point to the aortic valve annulus in short-axis reference plane and two reference points to make line markers centered in LV cavity from apex to mitral valve annulus in the three apical views (four-chamber, two-chamber and long-axis) to allow the LV long axis was designated and an exact volume reconstruction. Then the software automatically distinguished the LV endocardial border and tracked it for an entire cardiac cycle. An epicardial surface tracing could be generated by the system, which was manually adjusted to cover the full thickness of the LV wall. Before processing, a cine loop preview feature visually confirmed that the internal line followed the endocardium throughout the cardiac cycle. If tracking of the LV wall was unsatisfactory, manual adjustments were made. Last, the curves of global volume, 16 segmental volume and PS were produced automatically using the standard 16-segment model (Fig. 1). Global PS was calculated by averaging 16 segmental strain components. LV end-diastolic frame time and end-systolic frame time were located as the onset of QRS wave and the end of T wave respectively according to the electrocardiogram, which identified by the software automatically.
LV end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), LV mass, and global longitudinal strain (GLS), global circumferential strain (GCS), as well as twist, torsion were automatically calculated. Strain delay index (SDI), according to the method described previously [14], was determined as the sum of the difference between peak and end-systolic PS across 16 segments. Corrected by the R-R interval, the standard deviation of time to peak PS (TpPS-SD%) and the standard deviation of time to minimum systolic volume (Tmsv-SD%) were calculated using the standard 16-segment model.

Strain–volume loop reconstruction

The raw data were exported to a spreadsheet (Excel, Microsoft Corp, Washington, US). For each individual, data were plotted as PS (y-axis) against volume (x-axis) of each frame in a Cartesian system to develop the PS–volume loop across one cardiac cycle including systolic and diastolic components which was distinguished by the end-systolic frame time determined by the electrocardiogram: Global PS–Global volume loop, Segmental (Midseptal and Midlateral) PS–Global volume loop, as well as Segmental PS–Segmental volume loop including Midseptal PS–Midseptal volume loop and Midlateral PS–Midlateral volume loop (Fig. 2).
A linear fitting line was applied to each PS–volume loop and a polynomial regression analysis of the order y = kx + c was performed on the linear fitting line. The PS–volume loop was analyzed by two characteristics of the linear fitting curve: the slope and the coefficient of determination (R2-S/D coupling).

Inter- and intra-observer variability

Inter- and intra-observer variability of all 3D speckle-tracking imaging measures were assessed using Bland-Altman plots (Fig. 3) with data from 10 randomly selected study 3D images, examined twice by a second observer who was blinded to the values obtained by the first observer and by one observer twice who was blinded to the results of the previous measurements, respectively.

Statistics analysis

Continuous data are expressed as mean ± SD and dichotomous data as numbers and percentages. Dichotomized comparisons were assessed using Chi-square test or Fisher exact test as appropriate. Comparisons of values between control group and HF patients or values between responders and non-responders at baseline or 6-month follow-up were performed using the Independent-Samples T Test, while intragroup (responders or non-responders) comparisons of values between baseline state and 6-month follow-up, or characteristics of PS–volume loops between Midseptal and Midlateral were performed using the Paired -Samples T Test. To determine independent predictors of response to CRT, logistic regression analysis was performed. Significant variables selected in univariate logistic regression analysis (P < 0.05) were entered into the multivariate analysis. The optimal cut-off value which combine the higher value of specificity plus sensitivity was obtained through receiver operating characteristic (ROC) curve. Correlations between two variables were analyzed using Pearson’s test.
A two-sided P value < 0.05 was accepted as indicating statistical significance. All data were analyzed using SPSS version 24.0 (SPSS Inc., Chicago, IL, USA) and MedCalc version 12.5.0.0 (MedCalc Software, Mariakerke, Belgium).

Results

Study population

Twenty healthy subjects (62.9 ± 8.8 years, 30% female, 74.3 ± 9.5 beats/min) as control group and forty HF patients scheduled for CRT (60.3 ± 11.9 years, 25% female, 75.6 ± 16.3 beats/min) were included in this study. Of the 40 HF patients at 6-month follow-up, 27 patients (68%) were classified as responders while 13 patients (32%) were classified as non-responders. Baseline clinical characteristics of CRT responders versus non-responders are shown in Table 1, but no significant differences were observed in baseline clinical characteristics between them. Comparisons of 2D and 3D echocardiographic characteristics between controls and HF patients as well as between CRT responders and non-responders at baseline and at follow-up are presented in Table 2. Obviously, most structural parameters had been significantly changed and functional parameters had been significantly impaired in HF patients at baseline evaluation when compared with the control group. All HF patients were on stable, optimal medical treatment according to the ESC guidelines [10]. Baseline echocardiographic characteristics were comparable between responders and non-responders, except for better response among those patients with smaller LVESD and LVEDV. At 6-month follow-up, responders showed a significant decrease in LV size (diameter and volume) and LV dyssynchrony indices (TpPS-SD% and Tmsv-SD%), and a significant increase in the absolute value of GLS and GCS, whereas non-responders didn’t have any significant changes.
Table 1
Baseline clinical characteristics of CRT responders versus non-responders
Variable
Responders
Non-Responders
P Value
(n = 27)
(n = 13)
Age, years
61.5 ± 10
58.2 ± 15.2
.444
Female gender, n (%)
9 (33%)
1 (8%)
.113
Heart rate, beats/min
73.5 ± 11.5
79.6 ± 23.1
.407
SBP, mm Hg
121.8 ± 13
115.8 ± 18.6
.273
DBP, mm Hg
76 ± 8.3
70.5 ± 7.4
.065
NYHA functional class III/IV
23/4
8/5
.685
Ischemic Etiology, n (%)
7 (26%)
5 (38%)
.709
QRS
 duration (ms)
160.5 ± 24.1
158.3 ± 28.5
.812
 LBBB morphology, n (%)
20 (74%)
9 (69%)
.706
Mitral regurgitation > grade II, n (%)
15 (56%)
9 (77%)
.463
Hypertension, n (%)
14 (52%)
3 (23%)
.163
Diabetes, n (%)
6 (22%)
2 (15%)
1.000
Renal insufficiency, n (%)
3 (11%)
1 (8%)
1.000
Serum biomarkers
 CK-MB, U/L
11.5 ± 4.07
10.83 ± 3.69
.646
 CK-MM, U/L
53.4 ± 30.13
54 ± 31.79
.958
 Cre, μmol/L
84.74 ± 41.04
88.62 ± 15.48
.756
 hs CRP, mg/L
7.46 ± 15.96
3.27 ± 6.2
.513
 Uric acid, μmol/L
425.44 ± 148.55
479.03 ± 168.72
.340
 NT-proBNP, pg/mL
2684.83 ± 2658.35
2956.5 ± 2748.22
.786
 cTnT, ng/mL
0.02 ± 0.02
0.03 ± 0.02
.101
Medication, n (%)
 ACEI/ARBs
15 (55%)
7 (54%)
1.000
 Beta-blockers
13 (48%)
6 (46%)
1.000
 Diuretics and/or spironolactone
13 (48%)
6 (46%)
1.000
ACEI Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker, CK-MB Creatine kinase MB fraction, CK-MM Creatine kinase MM fraction, Cre Creatinine, cTnT Cardiac troponin T, DBP Diastolic blood pressure, hs CRP High sensitive C-reactive protein, LBBB Left bundle branch block, NT-proBNP N-terminal of the prohormone brain natriuretic peptide, NYHA New York Heart Association, SBP Systolic blood pressure
Data are expressed as number (percentage) or mean ± SD
Table 2
Comparisons of 2D and 3D echocardiographic characteristics
Variable
Controls
All Patients
P
Value
Baseline
Follow-up
Baseline versus Follow-up
Responders
Non-responders
P
Responders
Non-Responders
P
P Value
P Value
(n = 20)
(n = 40)
(n = 27)
(n = 13)
Value
(n = 27)
(n = 13)
Value
Responders
Non-responders
2D Echocardiographic Parameters
 Aortic root, mm
30.2 ± 2.7
33.9 ± 4.2
.001
34.4 ± 4.4
32.9 ± 3.7
.329
35.1 ± 5
32.9 ± 3.5
.206
.214
1.000
 LA, mm
34.2 ± 2.9
47.1 ± 10.7
.000
44.7 ± 11.6
51.9 ± 6.6
.054
41.6 ± 5.6
48.9 ± 7.2
.002
.121
.200
 LVEDD, mm
46.3 ± 5.1
68.9 ± 14.4
.000
68.8 ± 7.4
69.2 ± 23.1
.942
64 ± 10.1
75.8 ± 8.6
.002
.000
.392
 LVESD, mm
28.7 ± 3.0
60.2 ± 8.8
.000
58 ± 7.7
64.3 ± 9.6
.042
51.1 ± 11.5
64.8 ± 9.2
.001
.000
.759
 IVS, mm
8.5 ± 1.0
9.0 ± 1.4
.184
9 ± 1.5
8.8 ± 1.4
.685
9.6 ± 1.3
8.6 ± 1.4
.042
.094
.536
 LVPW, mm
9.1 ± 0.8
9.3 ± 1.3
.419
9.3 ± 1.4
9.3 ± 1.3
.880
9.5 ± 1
8.9 ± 1.2
.137
.497
.137
 PASP, mm Hg
30 ± 2.8
43.1 ± 15.8
.000
43.7 ± 14.7
47.1 ± 18.5
.574
32.3 ± 5.7
37.7 ± 9.7
.050
.001
.130
 DT, ms
168.8 ± 26.9
176.2 ± 52.5
.494
173.9 ± 51
160.6 ± 80.8
.619
188.3 ± 45.4
147.2 ± 44.6
.028
.355
.613
 S′ wave, cm/s
11.7 ± 2.2
5.8 ± 1.9
.000
6.1 ± 1.8
5.2 ± 1.9
.201
6.2 ± 1.6
4.5 ± 1.2
.003
.335
.126
3D Echocardiographic Parameters
 LVEDV, mL
59.5 ± 12.9
226.7 ± 95.8
.000
203.5 ± 78.7
271.2 ± 112.5
.045
151.5 ± 72.9
269.3 ± 106.5
.000
.000
.898
 LVESV, mL
22.2 ± 7
179.8 ± 89.4
.000
158.7 ± 77.8
220.3 ± 99.3
.051
103.8 ± 61.7
208.9 ± 84.6
.000
.000
.458
 LVEF, %
62.9 ± 7.9
22.9 ± 9.6
.000
24.4 ± 10.3
20 ± 7.7
.195
34.1 ± 8.5
22.9 ± 7.7
.001
.000
.165
 LV Mass, g
102.4 ± 18.8
239 ± 80.1
.000
229.1 ± 61.3
258 ± 108.3
.317
184.7 ± 61
279.3 ± 117
.003
.000
.049
 GLS, %
− 22.16 ± 4.33
−7.16 ± 3.38
.000
−7.89 ± 3.45
−5.77 ± 2.86
.077
−11.09 ± 2.67
−7.61 ± 3.47
.002
.000
.088
 GCS, %
−30.59 ± 6.8
−8.64 ± 4.42
.000
−9.22 ± 4.98
−7.53 ± 2.97
.291
− 13.41 ± 4.71
− 8.62 ± 3.33
.004
.000
.103
 Twist, °
15.63 ± 8.1
5.48 ± 5.9
.000
5.76 ± 6.94
4.89 ± 2.91
.695
5.64 ± 5.7
2.78 ± 3.53
.123
.942
.103
 Torsion, °/cm
2.16 ± 1.19
0.59 ± 0.64
.000
0.63 ± 0.76
0.51 ± 0.31
.619
0.66 ± 0.68
0.28 ± 0.32
.079
.857
.094
 SDI, %
−25.52 ± 20.9
− 33.44 ± 25.53
.253
−37.33 ± 28.56
−25.99 ± 17.07
.217
−35.48 ± 32.57
−20.95 ± 21.4
.173
.809
.468
Mechanical Dyssynchrony Indices
 TpPS-SD%, %
6.42 ± 2.57
11.73 ± 6.58
.000
11.2 ± 6.22
12.73 ± 7.4
.522
8.9 ± 3.26
10.15 ± 3.83
.317
.030
.320
 Tmsv-SD%, %
5.71 ± 1.3
11.74 ± 6.01
.000
11.95 ± 5.7
11.33 ± 6.82
.775
8.89 ± 3.8
10.04 ± 3.88
.405
.004
.555
DT Deceleration time, IVSd Interventricular septum diastole, LA Left atrial, LVEDD Left ventricular end-diastolic diameter, LVEDV Left ventricular end-diastolic volume, LVEF Left ventricular ejection fraction, LVESD Left ventricular end-systolic diameter, LVESV Left ventricular end-systolic volume, LVPWd Left ventricular posterior wall diastole, GCS Global circumferential strain, GLS Global longitudinal strain, PASP Pulmonary artery systolic pressure, PS Principal strain, SDI Strain delay index, Tmsv-SD% Standard deviation of time to minimum systolic volume corrected by R-R interval, TpPS-SD% Standard deviation of time to peak principal strain corrected by R-R interval
Data are expressed as number (percentage) or mean ± SD

Peak strain and strain–volume loop

Comparisons of peak strain and characteristics of strain–volume loops between controls and HF patients as well as between CRT responders and non-responders at baseline and at follow-up are shown in Table 3. Comparisons of peak strain and characteristics of strain–volume loops between Midlateral and Midseptal are shown in Table 4.
Table 3
Comparisons of peak strain and characteristics of strain-volume loops
Variable
Controls
(n = 20)
All Patients
(n = 40)
P
Value
Baseline
Follow-up
Baseline versus Follow-up
Responders
(n = 27)
Non-responders
(n = 13)
P
Value
Responders
(n = 27)
Non-Responders
(n = 13)
P
Value
P Value
Responders
P Value
Non-responders
Segmental peak strain
 MidLateral PSPeak
−38.6 ± 11.5
−14.7 ± 7.3
.000
−17.1 ± 7
−10.1 ± 5.7
.005
−20.8 ± 6.6
−13.2 ± 5.8
.002
.030
.239
 MidSeptal PSPeak
−51.6 ± 10.1
−12.5 ± 8
.000
−13 ± 8.8
−11.6 ± 6.5
.635
−22 ± 11
− 12.4 ± 7.8
.011
.001
.779
Characteristics of strain-volume loops
 Global PS-Global volume loop
  slope
1.08 ± 0.35
0.26 ± 0.11
.000
0.29 ± 0.11
0.21 ± 0.1
.062
0.43 ± 0.19
0.23 ± 0.1
.002
.001
.437
  R2-S/D coupling
0.99 ± 0.01
0.97 ± 0.05
.016
0.97 ± 0.05
0.96 ± 0.06
.441
0.99 ± 0.02
0.98 ± 0.02
.765
.055
.100
Segmental PS-Global volume loop
 MidLateral PS-Global volume loop
  slope
1.06 ± 0.4
0.32 ± 0.18
.000
0.38 ± 0.17
0.19 ± 0.12
.001
0.45 ± 0.22
0.23 ± 0.11
.003
.172
.235
  R2-S/D coupling
0.91 ± 0.08
0.79 ± 0.27
.019
0.84 ± 0.22
0.69 ± 0.34
.180
0.85 ± 0.15
0.83 ± 0.25
.839
.920
.262
 MidSeptal PS-Global volume loop
  slope
1.46 ± 0.57
0.19 ± 0.24
.000
0.2 ± 0.2
0.18 ± 0.3
.782
0.48 ± 0.34
0.21 ± 0.18
.004
.001
.717
  R2-S/D coupling
0.93 ± 0.04
0.54 ± 0.37
.000
0.44 ± 0.39
0.73 ± 0.26
.014
0.71 ± 0.29
0.66 ± 0.34
.680
.002
.636
Segmental PS-Segmental volume loop
 MidLateral PS-MidLateral volume loop
  slope
18.66 ± 7.41
3.85 ± 1.81
.000
4.39 ± 1.78
2.82 ± 1.44
.013
6.11 ± 2.88
3.21 ± 1.52
.000
.004
.184
  R2-S/D coupling
0.97 ± 0.04
0.93 ± 0.11
.149
0.95 ± 0.09
0.89 ± 0.15
.119
0.95 ± 0.08
0.89 ± 0.18
.194
.864
.991
 MidSeptal PS-MidSeptal volume loop
  slope
28.26 ± 10.34
6.05 ± 3.1
.000
6.67 ± 3.44
4.85 ± 1.93
.099
10.8 ± 7.22
4.83 ± 2.83
.002
.005
.987
  R2-S/D coupling
0.96 ± 0.06
0.91 ± 0.1
.052
0.89 ± 0.12
0.94 ± 0.06
.108
0.93 ± 0.13
0.81 ± 0.33
.269
.353
.215
PS Principal strain
Data are expressed as mean ± SD
Table 4
Comparison of peak strain and characteristics of strain-volume loops between MidLateral and MidSeptal
Variable
Controls (n = 20)
Baseline
Follow-up
Responders (n = 27)
Non-Responders (n = 13)
Responders (n = 27)
Non-Responders (n = 13)
MidLateral
MidSeptal
P
MidLateral
MidSeptal
P
MidLateral
MidSeptal
P
MidLateral
MidSeptal
P
MidLateral
MidSeptal
P
Segmental PSPeak
−38.6 ± 11.5
−51.6 ± 10.1
.000
−17.1 ± 7
−13 ± 8.8
.077
−10.1 ± 5.7
−11.6 ± 6.5
.392
−20.8 ± 6.6
−22 ± 11
.621
−13.2 ± 5.8
−12.4 ± 7.8
.701
Characteristics of strain-volume loops
 Segmental PS-Global volume loop
  slope
1.06 ± 0.4
1.46 ± 0.57
.002
0.38 ± 0.17
0.2 ± 0.2
.002
0.19 ± 0.12
0.18 ± 0.3
.887
0.45 ± 0.22
0.48 ± 0.34
.469
0.23 ± 0.11
0.21 ± 0.18
.646
  R2-S/D coupling
0.91 ± 0.08
0.93 ± 0.04
.373
0.84 ± 0.22
0.44 ± 0.39
.000
0.69 ± 0.34
0.73 ± 0.26
.721
0.85 ± 0.15
0.71 ± 0.29
.025
0.83 ± 0.25
0.66 ± 0.34
.203
 Segmental PS-Segmental volume loop
  slope
18.66 ± 7.41
28.26 ± 10.34
.000
4.39 ± 1.78
6.67 ± 3.44
.000
2.82 ± 1.44
4.85 ± 1.93
.000
6.13 ± 2.94
10.8 ± 7.22
.001
3.21 ± 1.52
4.83 ± 2.83
.040
  R2-S/D coupling
0.97 ± 0.04
0.96 ± 0.06
.446
0.95 ± 0.09
0.89 ± 0.12
.078
0.89 ± 0.15
0.94 ± 0.06
.241
0.95 ± 0.08
0.93 ± 0.13
.512
0.89 ± 0.18
0.81 ± 0.33
.520
PS Principal strain
Data are expressed as mean ± SD

Baseline evaluation

HF patients showed significantly reduced Midlateral and Midseptal peak PS than the control group (all P < 0.001) (Table 3). All kinds of PS–volume loops in control group were very steep and strong systolic–diastolic coupling (R2-S/D coupling) (Table 3). Obviously, the slope and R2-S/D coupling of Global PS–Global volume loop and Segmental (Midlateral and Midseptal) PS–Global volume loop in HF patients were significantly reduced when compared with that in controls (all P < 0.05) (Table 3). The same observations were showed in the slope of Midlateral PS–Midlateral volume loop and Midseptal PS–Midseptal volume loop in HF patients (all P < 0.001), but R2 - S/D coupling of both were similar to that in healthy subjects (all P > 0.05) (Table 3).
Midlateral peak PS was significantly higher in responders than in non-responders (− 17.1 ± 7 vs. -10.1 ± 5.7, P = 0.005), but the difference of Midseptal peak PS didn’t reach statistical significance (P = 0.635) (Table 3). The slope and R2-S/D coupling of Global PS–Global volume loop were comparable between responders and non-responders (all P > 0.05) (Table 3). However, responders showed significantly lower R2-S/D coupling of the Midseptal PS–Global volume loop (P = 0.014) as well as higher slope of the Midlateral PS–Global volume loop (P = 0.001) and higher slope of the Midlateral PS–Midlateral volume loop (P = 0.013) in comparison with non-responders (Table 3).
For each individual, segmental peak PS and characteristics of PS–volume loops between the septal and lateral wall were heterogeneous, which was even observed in healthy subjects with Midseptal peak PS and slope of Midseptal PS–Global volume loop were significantly higher than those of Midlateral (P < 0.001 and P = 0.002, respectively) (Table 4). Whereas in CRT responders at baseline, although difference of peak PS between Midseptal and Midlateral did not reach statistical significance, the slope and R2-S/D coupling of the Midseptal PS–Global volume loop were significantly lower than those of Midlateral PS–Global volume loop (P = 0.002 and P < 0.001, respectively) (Table 4). This abnormal segmental heterogeneity, contrary to the septal-lateral relationship in healthy subjects, was observed only in CRT responders but not in non-responders at baseline.
Segmental heterogeneity between Midlateral PS–Midlateral volume loop and Midseptal PS–Midseptal volume loop at baseline didn’t differ among three groups with the slope of the Midseptal PS–Midseptal volume loop was significantly higher than that of Midlateral PS–Midlateral volume loop (all P < 0.001) and no significant differences were observed in R2 - S/D coupling between them (all > 0.05) (Table 4).

Changes at follow-up after CRT

At 6-month follow-up, significant improvements in Midseptal and Midlateral peak PS, as well as in the slope of Global PS–Global volume loop, Midseptal PS–Global volume loop, Midlateral PS–Midlateral volume loop and Midseptal PS–Midseptal volume loop were observed only in CRT responders (all P < 0.05) but non-responders didn’t show any significant changes (Table 3). As a result, Midseptal peak PS as well as the slope of Global PS–Global volume loop, Midseptal PS–Global volume loop and Midseptal PS–Midseptal volume loop showed significantly higher values in responders than in non-responders (all P < 0.05) while there was no significant difference at baseline (Table 3).
Similarly, the R2-S/D coupling of the Midseptal PS–Global volume loop significantly improved only in responders (P = 0.002), so that R2-S/D coupling of Midseptal PS–Global volume loop in CRT responders is no longer lower than that in non-responders (baseline vs. follow-up: P = 0.014 vs. P = 0.680) (Table 3). Although segmental heterogeneity of R2-S/D coupling between Midseptal PS–Global volume loop and the Midlateral PS–Global volume loop was still existed in CRT responders, it attenuated to a great extent (baseline vs. follow-up: P < 0.001 vs. P = 0.025) (Table 4). Besides, responders no longer showed abnormal segmental heterogeneity of slope between Midseptal PS–Global volume loop and Midlateral PS–Global volume loop at follow-up (baseline vs. follow-up: P = 0.002 vs. P = 0.469) (Table 4).

Analyses to identify baseline predictors of response to CRT

Logistic regression analysis was performed to identify independent predictors of response to CRT (Table 5). All variables significantly associated with CRT response in univariate regression analysis were involved in multivariate regression analysis. R2-S/D coupling of Midseptal PS–Global volume loop at baseline (odds ratio 0.878, 95% CI 0.810–0.930, P = 0.028) was found to be an independent predictor of CRT response. The area under the ROC curve (AUC) of R2-S/D coupling of Midseptal PS–Global volume loop was greater than that of TpPS-SD%, Tmsv-SD% and SDI (all P < 0.05) (Fig. 4). The optimal cut-off value of R2-S/D coupling was recommended as 0.55 (AUC value, 0.856; sensitivity, 89%; specificity, 77%) which determined by ROC curve. Besides, R2-S/D coupling of Midseptal PS–Global volume loop at baseline was significant correlated with percentage change in LVESV (△LVESV%) at 6-month follow-up in comparison with baseline value (r = − 0.647, P < 0.001) (Fig. 5).
Table 5
Analyses to identify baseline predictors of response to CRT
Variable
Univariate Analysis
Multivariate Analysis
OR
95% CI
P
OR
95% CI
P
Age
1.011
1.000–1.023
.054
   
Female
7.071
0.774–64.575
.083
   
QRS duration
1.004
0.976–1.032
.806
   
LBBB
1.417
0.310–6.470
.653
   
NYHA class III
1.800
0.380–8.535
.459
   
Nonischemic Etiology
1.633
0.383–6.968
.508
   
NT-proBNP
1.006
0.990–1.020
.340
   
hs CRP
1.001
1.000–1.070
.420
   
LVESD
1.009
0.998–1.020
.123
   
LVEDV
1.001
0.999–1.004
.330
   
LVEF
1.003
0.930–1.082
.939
   
GLS
0.892
0.809–0.984
.022
0.820
0.490–0.995
.190
GCS
0.922
0.852–0.997
.042
0.962
0.657–1.000
.660
TpPS-SD%
1.006
0.999–1.013
.112
   
Tmsv-SD%
1.007
1.002–1.015
.048
1.002
1.000–1.001
.120
SDI
0.978
0.958–0.999
.041
0.990
0.680–1.000
.240
MidLateral PSPeak
0.818
0.697–0.960
.014
0.890
0.550–0.980
.150
Slope of MidLateral PS- Global volume loop
3.934
2.863–6.444
.016
2.880
1.230–6.700
.470
R2-S/D coupling of MidSeptal PS-Global volume loop
0.803
0.760–0.880
.009
0.878
0.810–0.930
.028
Slope of MidLateral PS-MidLateral volume loop
2.035
1.104–3.750
.023
1.796
0.980–3.000
.200
CI Confidence interval, GCS Global circumferential strain, GLS Global longitudinal strain, hs CRP High sensitive C-reactive protein, LVEDV Left ventricular end-diastolic volume, LVESD Left ventricular end-systolic diameter, NT-proBNP N-terminal of the prohormone brain natriuretic peptide, OR Odd ratio, PS Principal strain, SDI Strain delay index, Tmsv-SD% Standard deviation of time to minimum systolic volume corrected by R-R interval, TpPS-SD% Standard deviation of time to peak principal strain corrected by R-R interval

Discussion

The aim of our study was to explore whether the LV strain–volume loops, a novel approach linking the structural changes to functional alterations, could provide a new perspective for assessing LV remodeling in HF patients and reverse remodeling following CRT, in the hope of offering additional information for predicting response to CRT and exploiting additive value of this approach in selection of CRT candidates.
It has been demonstrated in our study that the absolute value of GLS, GCS increased and LV mechanical dyssynchrony indices (TpPS-SD% and Tmsv-SD%) reduced after CRT. However, such echocardiographic parameters at baseline didn’t show no significant differences between responders and non-responders. Similar results were found in previous studies [15]. Methods of dyssynchrony index assessment were studied extensively in the past but with incomplete success to predict outcome. Early enthusiasm towards such methods [16, 17] was dampened by the multicenter Predictors of Response to Cardiac Resynchronization Therapy (PROSPECT) trial [18] that manifested the dyssynchrony parameters had marked variability in prediction of the clinical composite score response (sensitivity 6–74%, specificity 35–91%) and prediction of LV end-systolic volume response (≥15% reduction; sensitivity 9–77%, specificity 31–93%). SDI, which was a concept of wasted work introduced by Lim et al. [14] and has been proven to have a strong predictive value for predicting response to CRT [19], was comparable between responders and non-responders at baseline and even had no significant change after CRT in our study. All these parameters have limiting ability to predict CRT response probably because none of them incorporates dynamic changing myocardial loading and stress state. As shown in our study, Midlateral peak PS was higher in responders than in non-responders, but Midseptal peak PS didn’t differ at baseline so that we couldn’t judge whether septal was working effective or not. Besides, in view of the difference of peak PS between Midseptal and Midlateral did not reach statistical significance, we couldn’t infer that the heterogeneity of segmental strain distribution in dyssynchrony LV. Therefore, Russell et al. [20] proposed the LV pressure-strain loop analysis which allows the estimation of regional and global LV work (quantified by strain rate multiplying by instantaneous LV-pressure) and furthermore introduced the wasted work ratio as an index to predict response to CRT [21]. Vecera et al. [22] also demonstrated the wasted work in the septum calculated by similar methods was a strong predictor of response to CRT. However, clinical use of the LV pressure-strain analysis is limited by the challenge to noninvasive acquire instantaneous LV pressure.
The new method based on simultaneous strain–load (volume or area) analysis has been applied in certain physiological state [23, 24] and pathological LV remodeling [25, 26]. Besides, it has been recently validated the same method with tagging cardiac magnetic resonance [27]. It took about 3–5 min to perform strain–volume loop analysis off-line for each patient after practice in our study. So, it would be more generally applicable in clinical use by virtue of its noninvasive and convenient. Considering LV mapping data [28] have shown that the mid-septal region was electrically activated first and U-shaped conduction pattern through the apical regions was imposed on the LV activation sequence by a transmural functional line of block located between the LV septum and the lateral wall with a prolonged activation time, our study focused on septal and lateral strain–volume relationship analysis at the mid-ventricular level, which not only enhancing reproducibility since segmental heterogeneity was most evident between septum and lateral wall but also enhancing operability by simplifying evaluation and reducing data loss. Firstly, our study explored characteristics of the LV PS–volume loops in healthy subjects to verify the reliability of this new method and provide reference foundation to the establishment of evaluation criteria of LV remodeling such as in HF. As expected, the healthy subjects showed the normal myocardial shortening and lengthening was well coupled to the simultaneous progressive reduction and expansion of volume. In healthy subjects, all kinds of PS–volume loops showed steep slope, indicating a good systolic and diastolic performance. Besides, a similar strain value could be observed for any given LV volume during systole and diastole in healthy individuals, which suggesting the presence of strong systolic–diastolic coupling. This result was concordant with previous study [23].
At baseline evaluation of HF patients, all kinds of PS–volume loops showed a lower slope when compared with that in healthy subjects. As a result of the simultaneous presence of chamber dilatation (rightward shift of the loop) and strain reduction (upward shift of the loop), the two parameters were moving in the opposite direction from the normal loops in the Cartesian system and we could observe significant alteration of the slope. Furthermore, dissociation occurred between systolic and diastolic strain at the same volume, which indicating the presence of uncoupling in the relationship between strain and volume in HF patients. In dyssynchronous LV, systolic–diastolic uncoupling of strain–volume loop reflects myocardial efficiency reducing because myocardial systolic shortening and diastolic lengthening doesn’t synchronize with chamber volume decreasing and increasing, which resulting in much wasted work globally or segmentally. In addition, strain–volume loop provides an intuitive visual representation to detect the response to CRT. As shown in our study, if CRT effective, a simultaneous volume reducing (leftward shift of the loop) and PS increasing (downward shift of the loop) would make the loop steeper and better systolic–diastolic coupling.
At baseline, the R2-S/D coupling of the Midseptal PS–Global volume loop in CRT responders was significantly lower than that in non-responders, besides, the R2-S/D coupling of the Midseptal PS–Global volume loop at baseline was found to be an independent predictor of CRT response in multivariate analysis whereas dyssynchrony parameters were not. This result indicated that much wasted myocardial work was located to the septum at baseline in CRT responders. The amount of septal wasted myocardial work at baseline was related to the magnitude of benefit following CRT. The more the septal wasted at baseline, the higher probability of response to CRT was achieved. Nevertheless, the slope of the Midseptal PS–Global volume loop didn’t show significant difference between CRT responders and non-responders. While the synchronism of global and segmental myocardium maintains higher level with good systolic-diastolic coupling, myocardial contractility could be reflected by the slope of strain-volume loop. But if higher degree dyssynchrony of global and segmental myocardium is presented with systolic-diastolic uncoupling, the slope of strain-volume loop would underestimate the myocardial contractility. After CRT, the slope and R2-S/D coupling of the Midseptal PS–Global volume loop as well as Midseptal peak PS were increased significantly, accompanied by a significant increase in the slope of Global PS–Global volume loop as well as GLS and GRS, which suggesting an improvement in septal efficiency following CRT could contribute to the improvement in LV global function.
Midlateral peak PS as well as the slope of Midlateral PS–Global volume loop and Midlateral PS–Midlateral volume loop in CRT responders were higher than in non-responders at baseline. Therefore, we speculate that the compensatory maintenance of LV lateral wall function at a certain level was associated with a favorable response to CRT, which might be inconsistent with the view of Zweerink [29]. In Zweerink’s study, absolute values of lateral wall strain, strain rate, and work were significantly higher in responders, but this finding is not getting the attention it deserved for further investigation and deeper analysis.
In addition, our results also indicated that applying CRT to patients with abnormal segmental heterogeneity between septum and LV lateral wall, which contrary to that in healthy subjects, may be more likely to response to CRT. This heterogeneous distribution of myocardial work can be rebalanced by restoring normal electrical activation following CRT. It is helpful to improve patient selection for CRT to identify this abnormal but reversible segmental heterogeneity. Electric activation delay generates contractile dyssynchrony, with early-activated septum earlier onset of shortening during isovolumetric contraction phase against a low afterload while late-activated lateral wall shortening against increased wall stress and loading at late systole into early relaxation [30]. The early-developed septal force is dissipated in generating sufficient energy to open the aortic valve and in stretching the late-activated lateral wall. The latter event represents wasted energy during early ejection. Passive stretch might influence regional myocardial contractility because changes of effective preload triggered local Frank-Starling mechanism. The passive pre-stretch would enable the late-activated segments to contract to a greater extent in order to compensate for the increased loading conditions. Thus, septal work efficiency being reduced and lateral function compensatory being improved together generate the abnormal segmental heterogeneity. CRT could improve septal work efficiency and normalize lateral function in responders, which making heterogeneous distribution of myocardial work significantly decrease significantly or even eliminate. As observed in our study, responders showed improvements in the slope and R2-S/D coupling of the Midseptal PS–Global volume loop after CRT, whereas no significant change was observed in characteristics of the Midlateral PS–Global volume loop.
Most probably as the result of an optimized local loading state by CRT, the slope of both the Midseptal PS–Midseptal volume loop and the Midlateral PS–Midlateral volume loop were significantly increased in responders after CRT.

Limitations

This study was performed in a single center, with a relatively small sample size. Therefore, we cannot draw definitive conclusions but only formulate a hypothesis that needs to be confirmed by future, larger, multi-center prospective trials.

Conclusions

Analysis of strain–volume loops could provide unique information for predicting response to CRT and may become a potential new tool to detect the beneficial effects of CRT on LV function. Our study demonstrated that assessment of wasted work in septum at baseline would be helpful to improve patient effective selection for CRT. R2-S/D coupling of Midseptal PS–Global volume loop at baseline is proved to have predictive value for predicting response to CRT.

Acknowledgements

The study was funded by the National Nature Science Foundation of China (Grant No. 81671685).

Funding

The study was funded by the National Nature Science Foundation of China (Grant No. 81671685).

Availability of data and materials

All datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
All patients had given informed consent, and the study design was approved by the Ethical Review Board of Zhongshan Hospital of Fudan University and complied with the Declaration of Helsinki.
Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Cardiac resynchronization-heart failure study I: the effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.CrossRef Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Cardiac resynchronization-heart failure study I: the effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.CrossRef
2.
Zurück zum Zitat Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108(8):929–32.CrossRef Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108(8):929–32.CrossRef
3.
Zurück zum Zitat Klimusina J, De Boeck BW, Leenders GE, Faletra FF, Prinzen F, Averaimo M, Pasotti E, Klersy C, Moccetti T, Auricchio A. Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients. Eur J Heart Fail. 2011;13(2):186–94.CrossRef Klimusina J, De Boeck BW, Leenders GE, Faletra FF, Prinzen F, Averaimo M, Pasotti E, Klersy C, Moccetti T, Auricchio A. Redistribution of left ventricular strain by cardiac resynchronization therapy in heart failure patients. Eur J Heart Fail. 2011;13(2):186–94.CrossRef
4.
Zurück zum Zitat Carasso S, Rakowski H, Witte KK, Smith P, Carasso D, Garceau P, Sasson Z, Parker JD. Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. J Am Soc Echocardiogr. 2009;22(3):242–50.CrossRef Carasso S, Rakowski H, Witte KK, Smith P, Carasso D, Garceau P, Sasson Z, Parker JD. Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. J Am Soc Echocardiogr. 2009;22(3):242–50.CrossRef
5.
Zurück zum Zitat Bernard A, Donal E, Leclercq C, Schnell F, Fournet M, Reynaud A, Thebault C, Mabo P, Daubert JC, Hernandez A. Impact of cardiac resynchronization therapy on left ventricular mechanics: understanding the response through a new quantitative approach based on longitudinal strain integrals. J Am Soc Echocardiogr. 2015;28(6):700–8.CrossRef Bernard A, Donal E, Leclercq C, Schnell F, Fournet M, Reynaud A, Thebault C, Mabo P, Daubert JC, Hernandez A. Impact of cardiac resynchronization therapy on left ventricular mechanics: understanding the response through a new quantitative approach based on longitudinal strain integrals. J Am Soc Echocardiogr. 2015;28(6):700–8.CrossRef
6.
Zurück zum Zitat Satriano A, Heydari B, Narous M, Exner DV, Mikami Y, Attwood MM, Tyberg JV, Lydell CP, Howarth AG, Fine NM, et al. Clinical feasibility and validation of 3D principal strain analysis from cine MRI: comparison to 2D strain by MRI and 3D speckle tracking echocardiography. Int J Cardiovasc Imaging. 2017;33(12):1979–92.CrossRef Satriano A, Heydari B, Narous M, Exner DV, Mikami Y, Attwood MM, Tyberg JV, Lydell CP, Howarth AG, Fine NM, et al. Clinical feasibility and validation of 3D principal strain analysis from cine MRI: comparison to 2D strain by MRI and 3D speckle tracking echocardiography. Int J Cardiovasc Imaging. 2017;33(12):1979–92.CrossRef
7.
Zurück zum Zitat Ahn HS, Kim YK, Song HC, Choi EJ, Kim GH, Cho JS, Ihm SH, Kim HY, Park CS, Youn HJ. The impact of preload on 3-dimensional deformation parameters: principal strain twist and torsion. Cardiovasc Ultrasound. 2017;15(1):22.CrossRef Ahn HS, Kim YK, Song HC, Choi EJ, Kim GH, Cho JS, Ihm SH, Kim HY, Park CS, Youn HJ. The impact of preload on 3-dimensional deformation parameters: principal strain twist and torsion. Cardiovasc Ultrasound. 2017;15(1):22.CrossRef
8.
Zurück zum Zitat Pedrizzetti G, Sengupta S, Caracciolo G, Park CS, Amaki M, Goliasch G, Narula J, Sengupta PP: Three-dimensional principal strain analysis for characterizing subclinical changes in left ventricular function. J Am Soc Echocardiogr 2014, 27(10):1041–1050 e1041. Pedrizzetti G, Sengupta S, Caracciolo G, Park CS, Amaki M, Goliasch G, Narula J, Sengupta PP: Three-dimensional principal strain analysis for characterizing subclinical changes in left ventricular function. J Am Soc Echocardiogr 2014, 27(10):1041–1050 e1041.
9.
Zurück zum Zitat Stefani L, De Luca A, Toncelli L, Pedrizzetti G, Galanti G. 3D strain helps relating LV function to LV and structure in athletes. Cardiovasc Ultrasound. 2014;12(1):33.CrossRef Stefani L, De Luca A, Toncelli L, Pedrizzetti G, Galanti G. 3D strain helps relating LV function to LV and structure in athletes. Cardiovasc Ultrasound. 2014;12(1):33.CrossRef
10.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–200.CrossRef
11.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). Europace. 2013;34(29):2281–329. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European heart rhythm association (EHRA). Europace. 2013;34(29):2281–329.
12.
Zurück zum Zitat Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, Hancock EW, Josephson M, Kligfield P, Kors JA, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association electrocardiography and arrhythmias committee, council on clinical cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):976–81.CrossRef Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, Hancock EW, Josephson M, Kligfield P, Kors JA, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association electrocardiography and arrhythmias committee, council on clinical cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):976–81.CrossRef
13.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233.CrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233.CrossRef
14.
Zurück zum Zitat Lim P, Buakhamsri A, Popovic ZB, Greenberg NL, Patel D, Thomas JD, Grimm RA. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008;118(11):1130–7.CrossRef Lim P, Buakhamsri A, Popovic ZB, Greenberg NL, Patel D, Thomas JD, Grimm RA. Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy. Circulation. 2008;118(11):1130–7.CrossRef
15.
Zurück zum Zitat Delgado V, Ypenburg C, Zhang Q, Mollema SA, Fung JW, Schalij MJ, Yu CM, Bax JJ. Changes in global left ventricular function by multidirectional strain assessment in heart failure patients undergoing cardiac resynchronization therapy. J Am Soc Echocardiogr. 2009;22(6):688–94.CrossRef Delgado V, Ypenburg C, Zhang Q, Mollema SA, Fung JW, Schalij MJ, Yu CM, Bax JJ. Changes in global left ventricular function by multidirectional strain assessment in heart failure patients undergoing cardiac resynchronization therapy. J Am Soc Echocardiogr. 2009;22(6):688–94.CrossRef
16.
Zurück zum Zitat Van Bommel RJ, Ypenburg C, Borleffs CJ, Delgado V, Marsan NA, Bertini M, Holman ER, Schalij MJ, Bax JJ. Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure. Am J Cardiol. 2010;105(8):1153–8.CrossRef Van Bommel RJ, Ypenburg C, Borleffs CJ, Delgado V, Marsan NA, Bertini M, Holman ER, Schalij MJ, Bax JJ. Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure. Am J Cardiol. 2010;105(8):1153–8.CrossRef
17.
Zurück zum Zitat Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44(9):1834–40.CrossRef Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44(9):1834–40.CrossRef
18.
Zurück zum Zitat Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–16.CrossRef Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation. 2008;117(20):2608–16.CrossRef
19.
Zurück zum Zitat Lim P, Donal E, Lafitte S, Derumeaux G, Habib G, Reant P, Thivolet S, Lellouche N, Grimm RA, Gueret P. Multicentre study using strain delay index for predicting response to cardiac resynchronization therapy (MUSIC study). Eur J Heart Fail. 2011;13(9):984–91.CrossRef Lim P, Donal E, Lafitte S, Derumeaux G, Habib G, Reant P, Thivolet S, Lellouche N, Grimm RA, Gueret P. Multicentre study using strain delay index for predicting response to cardiac resynchronization therapy (MUSIC study). Eur J Heart Fail. 2011;13(9):984–91.CrossRef
20.
Zurück zum Zitat Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, Haugaa KH, Opdahl A, Fjeld JG, Gjesdal O, et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work. Eur Heart J. 2012;33(6):724–33.CrossRef Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Remme EW, Haugaa KH, Opdahl A, Fjeld JG, Gjesdal O, et al. A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a non-invasive index of myocardial work. Eur Heart J. 2012;33(6):724–33.CrossRef
21.
Zurück zum Zitat Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Gjesdal O, Edvardsen T, Smiseth OA. Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions. Am J Phys Heart Circ Phys. 2013;305(7):H996–1003. Russell K, Eriksen M, Aaberge L, Wilhelmsen N, Skulstad H, Gjesdal O, Edvardsen T, Smiseth OA. Assessment of wasted myocardial work: a novel method to quantify energy loss due to uncoordinated left ventricular contractions. Am J Phys Heart Circ Phys. 2013;305(7):H996–1003.
22.
Zurück zum Zitat Vecera J, Penicka M, Eriksen M, Russell K, Bartunek J, Vanderheyden M, Smiseth OA. Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging. 2016;17(6):624–32.CrossRef Vecera J, Penicka M, Eriksen M, Russell K, Bartunek J, Vanderheyden M, Smiseth OA. Wasted septal work in left ventricular dyssynchrony: a novel principle to predict response to cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging. 2016;17(6):624–32.CrossRef
23.
Zurück zum Zitat Oxborough D, Heemels A, Somauroo J, McClean G, Mistry P, Lord R, Utomi V, Jones N, Thijssen D, Sharma S, et al. Left and right ventricular longitudinal strain-volume/area relationships in elite athletes. Int J Cardiovasc Imaging. 2016;32(8):1199–211.CrossRef Oxborough D, Heemels A, Somauroo J, McClean G, Mistry P, Lord R, Utomi V, Jones N, Thijssen D, Sharma S, et al. Left and right ventricular longitudinal strain-volume/area relationships in elite athletes. Int J Cardiovasc Imaging. 2016;32(8):1199–211.CrossRef
24.
Zurück zum Zitat Lord R, George K, Somauroo J, Stembridge M, Jain N, Hoffman MD, Shave R, Haddad F, Ashley E, Jones H, et al. Alterations in cardiac mechanics following ultra-endurance exercise: insights from left and right ventricular area-deformation loops. J Am Soc Echocardiogr. 2016;29(9):879–87 e871.CrossRef Lord R, George K, Somauroo J, Stembridge M, Jain N, Hoffman MD, Shave R, Haddad F, Ashley E, Jones H, et al. Alterations in cardiac mechanics following ultra-endurance exercise: insights from left and right ventricular area-deformation loops. J Am Soc Echocardiogr. 2016;29(9):879–87 e871.CrossRef
25.
Zurück zum Zitat Lilli A, Baratto MT, Del Meglio J, Chioccioli M, Magnacca M, Svetlich C, Ghidini Ottonelli A, Poddighe R, Comella A, Casolo G. Three-dimensional simultaneous strain-volume analysis describes left ventricular remodelling and its progression: a pilot study. Eur J Echocardiogr. 2011;12(7):520–7.CrossRef Lilli A, Baratto MT, Del Meglio J, Chioccioli M, Magnacca M, Svetlich C, Ghidini Ottonelli A, Poddighe R, Comella A, Casolo G. Three-dimensional simultaneous strain-volume analysis describes left ventricular remodelling and its progression: a pilot study. Eur J Echocardiogr. 2011;12(7):520–7.CrossRef
26.
Zurück zum Zitat Hulshof HG, van Dijk AP, George KP, Hopman MTE, Thijssen DHJ, Oxborough DL. Exploratory assessment of left ventricular strain-volume loops in severe aortic valve diseases. J Physiol. 2017;595(12):3961–71.CrossRef Hulshof HG, van Dijk AP, George KP, Hopman MTE, Thijssen DHJ, Oxborough DL. Exploratory assessment of left ventricular strain-volume loops in severe aortic valve diseases. J Physiol. 2017;595(12):3961–71.CrossRef
27.
Zurück zum Zitat Lilli A, Tessa C, Diciotti S, Croisille P, Clarysse P, Del Meglio J, Salvatori L, Vignali C, Casolo G: Simultaneous strain-volume analysis by three-dimensional echocardiography: validation in normal subjects with tagging cardiac magnetic resonance, J Cardiovasc Med (Hagerstown) 2017, 18(4):223–229. Lilli A, Tessa C, Diciotti S, Croisille P, Clarysse P, Del Meglio J, Salvatori L, Vignali C, Casolo G: Simultaneous strain-volume analysis by three-dimensional echocardiography: validation in normal subjects with tagging cardiac magnetic resonance, J Cardiovasc Med (Hagerstown) 2017, 18(4):223–229.
28.
Zurück zum Zitat Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C, Kloss M, Klein H. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation. 2004;109(9):1133–9.CrossRef Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C, Kloss M, Klein H. Characterization of left ventricular activation in patients with heart failure and left bundle-branch block. Circulation. 2004;109(9):1133–9.CrossRef
29.
Zurück zum Zitat Zweerink A, de Roest GJ, Wu L, Nijveldt R, de Cock CC, van Rossum AC, Allaart CP: Prediction of Acute Response to Cardiac Resynchronization Therapy by Means of the Misbalance in Regional Left Ventricular Myocardial Work. (1532–8414 (Electronic)). Zweerink A, de Roest GJ, Wu L, Nijveldt R, de Cock CC, van Rossum AC, Allaart CP: Prediction of Acute Response to Cardiac Resynchronization Therapy by Means of the Misbalance in Regional Left Ventricular Myocardial Work. (1532–8414 (Electronic)).
30.
Zurück zum Zitat Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J. 2005;26(1):91–8.CrossRef Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J. 2005;26(1):91–8.CrossRef
Metadaten
Titel
The value of left ventricular strain–volume loops in predicting response to cardiac resynchronization therapy
verfasst von
Mengruo Zhu
Haiyan Chen
Zibire Fulati
Yang Liu
Yangang Su
Xianhong Shu
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Cardiovascular Ultrasound / Ausgabe 1/2019
Elektronische ISSN: 1476-7120
DOI
https://doi.org/10.1186/s12947-019-0153-3

Weitere Artikel der Ausgabe 1/2019

Cardiovascular Ultrasound 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.